ACCRETAMAB - Trademark Details
Status: 800 - Registered And Renewed
Image for trademark with serial number 77178675
Serial Number
77178675
Registration Number
3653037
Word Mark
ACCRETAMAB
Status
800 - Registered And Renewed
Status Date
2019-04-10
Filing Date
2007-05-11
Registration Number
3653037
Registration Date
2009-07-14
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2009-04-28
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
FAHRENKOPF, PAUL E
Statements
Goods and Services
[Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases]
Goods and Services
Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
Goods and Services
Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
B - Sec. 8 - Class(es) in a Multiple Class registration -- Partial Cancellation
Class Status Date
2015-08-05
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2007-05-16
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2007-05-16
Primary Code
042
Current Trademark Owners
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
11 - 1st New Owner Before Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kaushal R. Odedra
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2007-04-252007041644JapanTrue
Trademark Events
Event DateEvent Description
2007-05-16NEW APPLICATION ENTERED IN TRAM
2007-08-24ASSIGNED TO EXAMINER
2007-08-24SUSPENSION LETTER WRITTEN
2007-08-24LETTER OF SUSPENSION MAILED
2008-02-24ASSIGNED TO LIE
2008-02-24LIE CHECKED SUSP - TO ATTY FOR ACTION
2008-03-25SUSPENSION INQUIRY WRITTEN
2008-03-26INQUIRY AS TO SUSPENSION MAILED
2008-06-09PAPER RECEIVED
2008-06-10CORRESPONDENCE RECEIVED IN LAW OFFICE
2008-06-10AMENDMENT FROM APPLICANT ENTERED
2008-06-11SUSPENSION LETTER WRITTEN
2008-06-11LETTER OF SUSPENSION MAILED
2008-11-19AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2008-12-11LIE CHECKED SUSP - TO ATTY FOR ACTION
2009-01-11SUSPENSION INQUIRY WRITTEN
2009-01-12INQUIRY AS TO SUSPENSION MAILED
2009-02-06PAPER RECEIVED
2009-02-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2009-02-09AMENDMENT FROM APPLICANT ENTERED
2009-02-09SUSPENSION INQUIRY WRITTEN
2009-02-10INQUIRY AS TO SUSPENSION MAILED
2009-02-23PAPER RECEIVED
2009-02-24CORRESPONDENCE RECEIVED IN LAW OFFICE
2009-02-24AMENDMENT FROM APPLICANT ENTERED
2009-03-23APPROVED FOR PUB - PRINCIPAL REGISTER
2009-03-23LAW OFFICE PUBLICATION REVIEW COMPLETED
2009-04-08NOTICE OF PUBLICATION
2009-04-28PUBLISHED FOR OPPOSITION
2009-07-14REGISTERED-PRINCIPAL REGISTER
2015-07-01TEAS SECTION 8 RECEIVED
2015-08-05CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2015-08-05REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
2015-08-05NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
2018-07-14COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
2019-04-08TEAS SECTION 8 & 9 RECEIVED
2019-04-10REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2019-04-10REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2019-04-10NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
2019-09-04AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP